Y Terashima

Resistance to anticancer drugs in NIH3T3 cells transfected with c-myc and/or c-H-ras genes

S Niimi, Kei Nakagawa, Jun Yokota et al. · British Journal of Cancer · 1991 · 91 citations · Full text

Medicine, Genetics, Oncology +14

Mechanism of cross-resistance to a camptothecin analogue (CPT-11) in a human ovarian cancer cell line selected by cisplatin.

S Niimi, Kei Nakagawa, Y. Sugimoto et al. · PubMed · 1992 · 51 citations

Medicine, Oncology, Pharmacology +16

[Phase II study of 254-S (cis-diammine glycolato platinum) for gynecological cancer].

Takeharu Kato, H Nishimura, M Yakushiji et al. · PubMed · 1992 · 47 citations

Medicine, Oncology, Pharmacology +17

A phase II trial of docetaxel in platinum pre-treated patients with advanced epithelial ovarian cancer: A Japanese Cooperative Study

Noriyuki Katsumata, Ryuichiro Tsunematsu, Kenichi Tanaka et al. · Annals of Oncology · 2000 · 41 citations · Full text

Medicine, Gynecology, Oncology +14

[A phase II clinical study of cis-diammine glycolato platinum, 254-S, for cervical cancer of the uterus].

K Noda, Mana Ikeda, M Yakushiji et al. · PubMed · 1992 · 23 citations

Medicine, Oncology, Pharmacology +17